Metabolism of lysosomal sialidase and molecular basis of sialidosis

溶酶体唾液酸酶的代谢和唾液酸贮积症的分子基础

基本信息

项目摘要

To gain insight into the pathogenesis of sialidosis, we performed molecular investigations of four unrelated Japanese patients, and identified five novel missense mutations causing amino acid substitutions, P80L, V217M,W240R, G243R and P316S, respectively. Using homology modeling, the structure of human lysosomal sialidase was constructed and the structural changes caused by these mutations were deduced. The results showed that the P80L and P316S transversions cause large conformational changes including the active site residues responsible for binding the sialic acid carboxylate group. The V217M, W240R and G243R substitutions were deduced to influence the molecular surface structure of a limited region of the constructed models, involving in the interaction with the protective protein/cathepsin A. The predicted change due to V217M was smaller than that caused by W240R or G243R, the latters resulting in a drastic, widespread alteration. The overexpressed gene products containing these mutations had the same molecular weight as that of the wild type, although the amounts of the products were moderately decreased. A biochemical study demonstrated that the expressed sialidase containing a V217M mutation was partly transported to lysosomes and showed residual enzyme activity, although other mutants were retained in the endoplasmic reticulum/Golgi area and had lost the enzyme activity. Considering the data, we surmise that the V217M substitution may be closely associated with the phenotype of sialidosis with a late onset and moderate clinical course
为了深入了解唾液酸中毒的发病机制,我们对4名无关的日本患者进行了分子研究,并确定了5个新的错义突变,分别引起氨基酸取代,P80 L,V217 M,W240 R,G243 R和P316 S。利用同源模建方法,构建了人溶酶体唾液酸酶的结构,并推导了这些突变引起的结构变化。结果表明,P80 L和P316 S的转换引起大的构象变化,包括负责结合唾液酸羧酸基团的活性位点残基。推测V217 M、W240 R和G243 R取代影响了构建的模型的有限区域的分子表面结构,涉及与保护蛋白/组织蛋白酶A的相互作用。V217 M引起的预测变化小于W240 R或G243 R引起的变化,后者导致了剧烈的,广泛的变化。含有这些突变的过表达基因产物具有与野生型相同的分子量,尽管产物的量适度降低。一项生化研究表明,表达的唾液酸酶含有V217 M突变被部分转运到溶酶体,并显示残留的酶活性,虽然其他突变体被保留在内质网/高尔基体区域,并失去了酶活性。考虑到这些数据,我们推测V217 M置换可能与晚发性和中度临床病程的唾液酸沉积症表型密切相关

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takiguchi, K., et al.: "Structural and functional study of K453E mutant protective protein/cathepsin A causing the late infantile form of galactosialidosis"J. Hum. Genet.. 45. 200-206 (2000)
Takiguchi, K. 等人:“K453E 突变保护蛋白/组织蛋白酶 A 引起婴儿晚期半乳糖唾液酸贮积症的结构和功能研究”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itoh, K., et al.: "Endothelin-1 in the brain of patients with galactosialidosis : Its abnormal increase and distribution pattern"Ann.Neurol.. 47. 122-126 (2000)
Itoh, K., et al.:“半乳糖唾液酸贮积症患者大脑中的内皮素-1:其异常增加和分布模式”Ann.Neurol.. 47. 122-126 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itoh, K., et al.: "Novel missense mutations in the human lysosomal sialidase gene causing sialidosis and structural prediction of mutant enzymes"J. Hum. Genet.. 47. 29-37 (2002)
Itoh, K. 等人:“人溶酶体唾液酸酶基因中引起唾液酸贮积症的新型错义突变和突变酶的结构预测”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakuraba, H., et al.: "Molecular and structural studies of the GM2 gangliosidosis 0 variant."J. Hum. Genet.. (in press).
Sakuraba, H. 等人:“GM2 神经节苷脂沉积症 0 变体的分子和结构研究。”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakuraba, H., et al.: "Molecular and structural studies of the GM2 gangliosidosis 0 variant"J.Hum.Genet.. 47. 176-183 (2002)
Sakuraba, H., et al.:“GM2 神经节苷脂沉积症 0 变体的分子和结构研究”J.Hum.Genet.. 47. 176-183 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKURABA Hitoshi其他文献

ハニカム構造フィルム上におけるフィブロネクチンの吸着構造と細胞接着
蜂窝结构膜上的纤连蛋白吸附结构和细胞粘附
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    V Laquintana;N Denora;A Lopedota;H Suzuki;M Sawada;M Serra;G Biggio A Latrofa;G Trapani;G Liso;IMAI Fumihiro;NAGATSU Toshiharu;SAKURABA Hitoshi;HAYASHI Yoshinori;Yamada Jun;S. Yamamoto,;ITO Sachiko;S. Yamamoto;SAWADA Makoto;NAGATSU Toshiharu;山本貞明;S.Yamamoto;S.Yamamoto;澤田 誠;A.Tsuruma;SAWADA Makoto;山本貞明
  • 通讯作者:
    山本貞明

SAKURABA Hitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKURABA Hitoshi', 18)}}的其他基金

Development of a new biomarker of GM2 gangliosidosis
GM2 神经节苷脂沉积症新生物标志物的开发
  • 批准号:
    23659527
  • 财政年份:
    2011
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Thermodynamic and structural study on the interaction of an enzyme and a substrate analogue for development of new therapy for lysosomal diseases
酶与底物类似物相互作用的热力学和结构研究,用于开发溶酶体疾病新疗法
  • 批准号:
    21390314
  • 财政年份:
    2009
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structure-based modification of lysosomal enzymes: development of new enzyme replacement therapy for lysosomal diseases
基于结构的溶酶体酶修饰:开发溶酶体疾病的新酶替代疗法
  • 批准号:
    18390303
  • 财政年份:
    2006
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of enzyme replacement therapy for lysosomal diseases using yeast expression system.
使用酵母表达系统开发溶酶体疾病的酶替代疗法。
  • 批准号:
    15591149
  • 财政年份:
    2003
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural analysis and molecular designing of enzyme proteins : Its application to clarification of pathology of inherited metabolic diseases and development of therapy
酶蛋白的结构分析和分子设计:其在遗传性代谢疾病病理学阐明和治疗开发中的应用
  • 批准号:
    08670932
  • 财政年份:
    1996
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Three-dimensional imaging of cells and tissues for the clarification of pathogenesis of inherited metabolic diseases.
细胞和组织的三维成像,用于阐明遗传性​​代谢疾病的发病机制。
  • 批准号:
    06670847
  • 财政年份:
    1994
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Gene expression and its application to the investigation on pathogenesis of congenital metabolic diseases and development of therapy for them.
基因表达及其在先天性代谢性疾病发病机制研究和治疗开发中的应用。
  • 批准号:
    03670516
  • 财政年份:
    1991
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Functional elucidation of influenza virus sialidase by intracellular enzymatic activity imaging probe.
通过细胞内酶活性成像探针阐明流感病毒唾液酸酶的功能。
  • 批准号:
    23K16306
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of sialidase inhibitors for treatment of idiopathic pulmonary fibrosis
开发治疗特发性肺纤维化的唾液酸酶抑制剂
  • 批准号:
    23K05054
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Significance of glycoconjugate remodeling by fish sialidase localizing at nucleus
位于细胞核的鱼类唾液酸酶对糖缀合物重塑的意义
  • 批准号:
    22H02436
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
剖析唾液酸和唾液酸酶在牙龈卟啉单胞菌病理生理学中的作用
  • 批准号:
    10545715
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
剖析唾液酸和唾液酸酶在牙龈卟啉单胞菌病理生理学中的作用
  • 批准号:
    10350709
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
Development of Location-specific Sialidase Inhibitors
位置特异性唾液酸酶抑制剂的开发
  • 批准号:
    10359898
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
Synthetic chemistry for the development of oligosaccharide-type sialidase inhibitors
用于开发寡糖型唾液酸酶抑制剂的合成化学
  • 批准号:
    21H02070
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of sialidase inhibitors for treatment of idiopathic pulmonary fibrosis
开发治疗特发性肺纤维化的唾液酸酶抑制剂
  • 批准号:
    21K19072
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Elucidating the role of sialic acids and sialidase in the pathogenesis of Porphyromonas ginigvalis
阐明唾液酸和唾液酸酶在牙龈卟啉单胞菌发病机制中的作用
  • 批准号:
    10183139
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
Evaluating NanH Sialidase Contributions to Growth, Sporulation and Toxin Action for C. perfringens Type F Food Poisoning Strains
评估 NanH 唾液酸酶对产气荚膜梭菌 F 型食物中毒菌株生长、孢子形成和毒素作用的贡献
  • 批准号:
    10115594
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了